RAD21 and coronary artery disorder: The occurrence of CHD was as follows: NIPBL mutation carriers (26.73% or 58/217), RAD21 mutation carriers (25.58% or 11/43), SMC1A mutation carriers (24.14% or 14/58), and HDAC8 mutation carriers (16.33% or 8/49).